Address About Our Vision
We’ve built the world’s most successful cigarette company, with the world’s most popular and iconic brands. Now we’ve made a dramatic decision. We will be far more than a leading cigarette company. We’re building PMI’s future on smoke-free products that are a much better choice than cigarette smoking. Indeed, our vision – for all of us at PMI – is that these products will one day replace cigarettes.
Why are we doing this? Because we should … We understand the millions of men and women who smoke cigarettes. They are looking for less harmful, yet satisfying, alternatives to smoking. We will give them that choice. We have a commitment to our employees and our shareholders. We will fulfill that commitment by pursuing this long-term vision for success. Society expects us to act responsibly. And we are doing just that, by delivering a smoke-free future. … And because we now can. Success in the cigarette business gives us the resources to pursue our ambitious vision. Thanks to the imagination and perseverance of thousands of people at PMI, we have developed breakthrough products that are smoke-free and enjoyable.
Main purpose of the role: Support our Smoke Free Products' categories from a Product Policy perspective.
Accountabilities:
Deliverables:
Desired profile:
PMI is an Equal Opportunity Employer PMI Global Services Inc. and PM Global Brands Inc. are a subsidiary of Philip Morris International Inc. Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue to smoke, society, the company, its shareholders and its other stakeholders. PMI is a leading international tobacco company engaged in the manufacture and sale of cigarettes, as well as smoke-free products, associated electronic devices and accessories, and other nicotine-containing products in markets outside the U.S. In addition, PMI ships versions of its IQOS Platform 1 device and consumables to Altria Group, Inc. for sale under license in the U.S., where these products have received marketing authorizations from the U.S. Food and Drug Administration (FDA) under the premarket tobacco product application (PMTA) pathway; the FDA has also authorized the marketing of a version of IQOS and its consumables as a Modified Risk Tobacco Product (MRTP), finding that an exposure modification order for these products is appropriate to promote the public health. PMI is building a future on a new category of smoke-free products that, while not risk-free, are a much better choice than continuing to smoke. Through multidisciplinary capabilities in product development, state-of-the-art facilities and scientific substantiation, PMI aims to ensure that its smoke-free products meet adult consumer preferences and rigorous regulatory requirements. PMI's smoke-free product portfolio includes heat-not-burn and nicotine-containing vapor products. As of September 30, 2022, PMI's smoke-free products are available for sale in 70 markets in key cities or nationwide, and PMI estimates that approximately 13.5 million adults around the world, excluding Russia and Ukraine have already switched to IQOS and stopped smoking.
For more information, please visit www.pmi.com and www.pmiscience.com.
#LI-Hybrid
We’ve built the world’s most successful cigarette company, with the world’s most popular and iconic brands. Now we’ve made a dramatic decision. We will be far more than a leading cigarette company. We’re building PMI’s future on smoke-free products that are a much better choice than cigarette smoking. Indeed, our vision – for all of us at PMI – is that these products will one day replace cigarettes.
Why are we doing this? Because we should … We understand the millions of men and women who smoke cigarettes. They are looking for less harmful, yet satisfying, alternatives to smoking. We will give them that choice. We have a commitment to our employees and our shareholders. We will fulfill that commitment by pursuing this long-term vision for success. Society expects us to act responsibly. And we are doing just that, by delivering a smoke-free future. … And because we now can. Success in the cigarette business gives us the resources to pursue our ambitious vision. Thanks to the imagination and perseverance of thousands of people at PMI, we have developed breakthrough products that are smoke-free and enjoyable.
Main purpose of the role: Support our Smoke Free Products' categories from a Product Policy perspective.
Accountabilities:
- Provides support from an External Affairs (EA) Product Policy perspective to all products covered by the respective Smoke Free Products' categories (incl. products in the pipeline) in order to deliver EA’s assessment and advice, securing coherence of regulatory approach across all Smoke Free Products categories
- Monitors regulatory developments & trends related to Smoke Free Products categories impacting regulatory (product) classification, product features, commercial freedoms, etc.
- Monitors the market in terms of emerging Smoke Free Products (incl. products which may be considered as substitutes) and regulatory developments related to these products, in order to identify regulatory opportunities and threats, and identify potential directions in which regulations can evolve, to better inform strategic decisions of the Smoke Free Products Categories Managements
- In close collaboration and alignment with EA Category Heads, Regulatory Policy and Fiscal Policy Teams, prepares recommendations on regulatory approach (e.g., regulatory classification / product definitions, etc.)
- Engages with markets to provide bespoke EA Product Policy advice & materials, in line with the approach agreed with the Smoke Free Products Categories Managements
- Elaborates strategies on how regulations could evolve to ensure products can be placed and maintained on the markets
Deliverables:
- Provides analysis of current regulatory environment as well as emerging regulatory trends vs their impact on the current Smoke Free Products portfolio and future product innovation
- Actively contributes to development of regulatory recommendations, in close collaboration with other EA Policy teams (Regulatory, Fiscal, ESG)
- Provides narratives to EA regions and markets
- Provides assessments of new products (design and composition) against current and future regulations
- Provides input on regulatory blueprints
Desired profile:
- Education: Scientific background (physics, chemistry, biology or related fields)
- Related work experience (8 years +)
- Scientific/Regulatory/Gov/corporate Affairs (market, region, HQ) in highly regulated products (tobacco & nicotine a plus)
- Good business understanding & Experience in collaboration with commercial teams is a plus
- Experience in commercial is a plus
- Ability to develop and prepare issue papers, advocacy materials and executive-level presentations that are impactful, comprehensible and bridge policy and politics
- Ability to analyze the link between regulatory framework / trends and business development / product commercialization (e.g., identifying regulatory risks vs opportunities in the context of product portfolio development)
- Ability to analyze issues and develop logical, customer-centric solutions, and distill into a concise, comprehensible and impactful recommendations
- Ability to manage complexity and collaboration with numerous cross-functional teams (PBO)
- Strong interpersonal skills, analytical skills, agility, resilience, outcome orientation
PMI is an Equal Opportunity Employer PMI Global Services Inc. and PM Global Brands Inc. are a subsidiary of Philip Morris International Inc. Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue to smoke, society, the company, its shareholders and its other stakeholders. PMI is a leading international tobacco company engaged in the manufacture and sale of cigarettes, as well as smoke-free products, associated electronic devices and accessories, and other nicotine-containing products in markets outside the U.S. In addition, PMI ships versions of its IQOS Platform 1 device and consumables to Altria Group, Inc. for sale under license in the U.S., where these products have received marketing authorizations from the U.S. Food and Drug Administration (FDA) under the premarket tobacco product application (PMTA) pathway; the FDA has also authorized the marketing of a version of IQOS and its consumables as a Modified Risk Tobacco Product (MRTP), finding that an exposure modification order for these products is appropriate to promote the public health. PMI is building a future on a new category of smoke-free products that, while not risk-free, are a much better choice than continuing to smoke. Through multidisciplinary capabilities in product development, state-of-the-art facilities and scientific substantiation, PMI aims to ensure that its smoke-free products meet adult consumer preferences and rigorous regulatory requirements. PMI's smoke-free product portfolio includes heat-not-burn and nicotine-containing vapor products. As of September 30, 2022, PMI's smoke-free products are available for sale in 70 markets in key cities or nationwide, and PMI estimates that approximately 13.5 million adults around the world, excluding Russia and Ukraine have already switched to IQOS and stopped smoking.
For more information, please visit www.pmi.com and www.pmiscience.com.
#LI-Hybrid
